Daniel Shu

4PUBLICATIONS
60CO-AUTHORS
Solid tumoursPredictive and prognostic markersMolecular targetsCancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (4)

|Aug 15, 2025
Neoadjuvant Immunotherapy Promotes the Formation of Mature Tertiary Lymphoid Structures in a Remodeled Pancreatic Tumor Microenvironment.

Dimitrios N Sidiropoulos, Sarah M Shin, Meredith Wetzel

|May 19, 2025
Nivolumab and Relatlimab for the Treatment of Patients with Unresectable or Metastatic Mismatch Repair-Proficient Colorectal Cancer.

Eric S Christenson, Won Jin Ho, Daniel Shu

|Oct 10, 2024
Spatial multi-omics reveal intratumoral humoral immunity niches associated with tertiary lymphoid structures in pancreatic cancer immunotherapy pathologic responders.

Dimitrios N Sidiropoulos, Sarah M Shin, Meredith Wetzel

|Jul 24, 2023
Salvage Ipilimumab plus Nivolumab after Anti-PD-1/PD-L1 Therapy in Advanced Hepatocellular Carcinoma.

Stephanie L Alden, Mir Lim, Chester Kao

Pageof 1

Frequent Collaborators

4 joint publications

Won Jin Ho

3 joint publications

Mark Yarchoan

3 joint publications

Elizabeth M Jaffee

2 joint publications

Dimitrios N Sidiropoulos